SCHEMBL18258263

SCHEMBL18258263

COCC1COC(Cn2cncn2)(c2ccccc2)O1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.61
NPSR1 Q6W5P4 1/20 0.61
GAA P10253 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CYP3A4 P08684 13/20 0.51
THRB P10828 1/20 0.51
ADRA1D P25100 5/20 0.44
ADRA1A P35348 5/20 0.44
LMNA P02545 2/20 0.44
FYN P06241 2/20 0.44
CYP51A1 Q16850 2/20 0.44
NR1I2 O75469 1/20 0.44
PGR P06401 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
CHRM1 P11229 1/20 0.44
TSHR P16473 1/20 0.44
ADRA2B P18089 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18257806 0.88 HSP90AA1 (0.58) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL18857006 0.88 HSP90AA1 (0.58) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL11400857 0.86 CYP3A4 (0.68) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL24113842 0.86 HSP90AA1 (0.55) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL24113843 0.86 HSP90AA1 (0.55) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL9458038 0.86 HSP90AA1 (0.57) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL11544305 0.82 HSP90AA1 (0.57) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL28608936 0.82 HSP90AA1 (0.57) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL28602335 0.82 HSP90AA1 (0.57) HSP90AA1NPSR1GAAHSD17B10CYP3A4
SCHEMBL18241659 0.82 HSP90AA1 (0.61) HSP90AA1NPSR1GAAHSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099679-B1 ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF UNIV CONNECTICUT (US) 2020-05-20 EP disclosed
US-9839636-B2 Itraconazole analogues and methods of use thereof UNIVERSITY OF CONNECTICUT (US) 2017-12-12 US disclosed
US-20170209436-A1 ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-07-27 US disclosed
US-9650365-B2 Itraconazole analogues and methods of use thereof UNIVERSITY OF CONNECTICUT (US) 2017-05-16 US disclosed
US-20160340346-A1 ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340346-A1 ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF GLI1, SHH, SMO HSP90AA1 3321/4885NPSR1 4536/4885GAA 3471/4885
US-20170209436-A1 ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF GLI1, SHH, SMO HSP90AA1 3321/4885NPSR1 4536/4885GAA 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.